1life Healthcare (NASDAQ:ONEM) had its price target boosted by Piper Sandler from $29.00 to $40.00 in a report released on Tuesday morning, The Fly reports. The brokerage currently has an overweight rating on the stock.
A number of other equities research analysts also recently issued reports on ONEM. Morgan Stanley upped their price objective on shares of 1life Healthcare from $21.00 to $35.00 and gave the stock an overweight rating in a research report on Monday, May 18th. Zacks Investment Research raised 1life Healthcare from a sell rating to a hold rating in a report on Thursday, June 25th. SunTrust Banks lifted their price target on 1life Healthcare from $26.00 to $30.00 and gave the stock a buy rating in a report on Thursday, May 14th. Citigroup cut their price objective on 1life Healthcare from $25.00 to $20.00 and set a neutral rating on the stock in a research report on Wednesday, April 1st. Finally, Wells Fargo & Co raised their target price on 1life Healthcare from $18.00 to $23.00 and gave the company an equal weight rating in a research report on Thursday, May 14th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock has a consensus rating of Buy and a consensus price target of $30.56.
Shares of 1life Healthcare stock opened at $36.32 on Tuesday. 1life Healthcare has a one year low of $15.00 and a one year high of $42.00. The company has a 50-day moving average price of $32.83. The company has a market cap of $4.02 billion and a price-to-earnings ratio of -12.79.
1life Healthcare (NASDAQ:ONEM) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.23). The business had revenue of $78.76 million during the quarter, compared to analyst estimates of $74.79 million. As a group, research analysts forecast that 1life Healthcare will post -1.05 EPS for the current year.
Several institutional investors and hedge funds have recently modified their holdings of ONEM. Ameritas Investment Partners Inc. purchased a new position in shares of 1life Healthcare during the 1st quarter valued at $30,000. Victory Capital Management Inc. purchased a new stake in 1life Healthcare in the 1st quarter worth about $55,000. Lindbrook Capital LLC bought a new stake in 1life Healthcare in the 1st quarter valued at about $73,000. Strs Ohio purchased a new stake in 1life Healthcare during the first quarter valued at about $88,000. Finally, Citigroup Inc. purchased a new stake in 1life Healthcare during the first quarter valued at about $101,000. Hedge funds and other institutional investors own 50.95% of the company’s stock.
About 1life Healthcare
1Life Healthcare, Inc operates a membership-based primary care platform. The company develops a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. It also provides medical services in-office and virtually. As of September 30, 2019, the company had approximately 397,000 members in 9 markets in the United States; 6,000 enterprise clients; and health network partnerships.
Featured Story: What is the Rule of 72?
Receive News & Ratings for 1life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.